Bibliography
- World Health. World Health Statistics 2008. 4th edition. ISBN-13 9789241563598
- Center for Disease Control. National Center for Health Statistics. Cardiovascular Disease Mortality Trends for Men and Women. United States: 1979-2003
- Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med 1999;340:115-26
- Okura Y, Takao M, Zhang B, et al. Cardiovascular risk factor profiles and endothelial function in coronary artery disease patients treated with statins. Hypertens Res 2004;27:723-9
- Dawber TR, Kannel WB. The Framingham study: an epidemiological approach to coronary heart disease. Circulation 1966;34:553-5
- Wilson PWF, D'agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47
- Grundy SM, Pasternak R, Greenland P, et al. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 1999;100:1481-92
- O'Donoghue M., Morrow DA. The future of biomarkers in the management of patients with acute coronary syndromes. Curr Opin Cardiol 2008;23:309-314
- Bassuk SS, Rifai N, Ridker PM. High sensitivity C-reactive protein: clinical importance. Curr Prob Cardiol 2004;29:439-93
- Ridker PM. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk. Moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol 2007;49:2129-38
- Pradhan AD, Manson JE, Rossouw JE, et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the women's health initiative observational study. J Am Med Assoc 2002;288:980-7
- Sander K, Horn CS, Briesenick C, Sander D. High-sensitivity C-reactive protein is independently associated with early carotid artery progression in women but not in men: the INVADE study. Stroke 2007;38:2881-6
- Rohde LEP, Hennekens CH, Ridker PM. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am J Cardiol 1999;84:1018-22
- Ridker PM, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9
- Hamirani YS, Pandy S, Rivera JJ, et al. Markers of inflammation and coronary calcification: a systematic review. Atherosclerosis 2008;20:1-7
- Arad Y, Goodman KJ, Roth M, et al. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events. The St. Francis Heart Study. J Am Coll Cardiol 2005;46:158-65
- Folsom AR, Aleksic N, Catellier D, et al. C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J 2002;144:233-8
- Mehta SK, Rame JE, Khera A, et al. Left ventricular hypertrophy, subclinical atherosclerosis, and inflammation. Hypertension 2007;49:1385-91
- Ballantyne CM, Hoogeveen RC, Bang H, et al. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2004;109:837-42
- Van der Meer IM, de Maat MPM, Bots ML, et al. Inflammatory mediators and cell adhesion molecules as indicators of severity of atherosclerosis: the Rotterdam Study. Arterioscler Thromb Vasc Biol 2002;22:838-42
- Khera A, de Lemos JA, Peshock RM, et al. Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study. Circulation 2006;113:38-43
- Cook NR. Use and misuse of the receiver operating characteristic curve in risk predictioin. Circulation 2007;115:928-935
- Ridker PM, Danielson E, Fonseca FAH, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-207
- Aukrust P, Halvorsen B, Yndestad A, et al. Arteriosclerosis, Thrombosis and Vascular Biology. 2008;28:1-10
- Deo R, Khera A, Mcguire DK, et al. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J Am Coll Cardiol 2004;44:1812-8
- Norata GD, Ongari M, Garlaschelli K, et al. Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur J Endocrinol 2007;156:279-84
- Apple FS, Pearce LA, Chung A, et al. Multiple biomarker use for detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem 2007;53:874-81
- Morrow D, Sabatine MS, Brennan ML, et al. Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: Myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18. Eur Heart J 2008;29:1096-1102
- Meuwese MC, Stroes ESG, Hazen SL, et al. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals. The EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol 2007;50:159-65
- Schillinger M, Exner M, Mlekusch W, et al. Inflammation and carotid artery- risk for atherosclerosis study (ICARAS). Circulation 2005;111:2203-9
- Exner M, Minar E, Mlekusch W, et al. Myeloperoxidase predicts progression of carotid stenosis in states of low high-density lipoprotein cholesterol. J Am Coll Cardiol 2006;47:2212-8
- Rho YH, Chung CP, Oeser A, et al. Novel cardiovascular risk factors in premature coronary atherosclerosis associated with systemic lupus erythematosus. J Rheumatol 2008;35:1789-94
- Shuijf JD, Poldermans D, Shaw LJ, et al. Diagnostic and prognostic value of non-invasive imaging in known or suspected coronary artery disease. Eur J Nucl Medicine Mol Imaging 2006;33:93-104
- Djaberi R, Beishuizen ED, Pereira AM, et al. Non-invasive cardiac imaging techniques and vascular tools for the assessment of cardiovascular disease in type 2 diabetes mellitus. Diabetologia 2008;51:1581-93
- Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC Guidelines for the clinical use of cardiac radionuclide imaging- executive summary: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. Circulation 2003;108:1404-18
- Stress Echocardiography Writing Group; ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR. Appropriateness Criteria for Stress Echocardiography. Circulation 2008;117:1478-97
- Bax JJ, Bonow RO, Tschope D, et al. The potential of myocardial perfusion scintigraphy for risk stratification of asymptomatic patients with type 2 diabetes. J Am Coll Cardiol 200648:754-760
- Sabeti S, Schlager O, Exner M, et al. Progression of carotid stenosis detected by duplex ultrasonography predicts adverse outcomes in cardiovascular high-risk patients. Stroke 2007;38:2887-94
- Goessens BMB, Visseren FLJ, Kappelle LJ, et al. Asymptomatic carotid artery stenosis and the risk of new vascular events in patients with manifest arterial disease: the SMART study. Stroke 2007;38:1470-5
- Lorenz MW, Markus HS, Bots ML, et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007;115:459-67
- Sharrett AR, Ding J, Criqui MH, et al. Smoking, diabetes, and blood cholesterol differ in their associations with subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2006;186:441-7
- Vicenzini E, Ricciardi MC, Puccinelli F, et al. Sonographic carotid plaque morphologic characteristics and vascular risk factors. Results from a population study. J Ultrasound Med 2008;27:1313-9
- Anand DV, Lim E, Lahiri A, Bax, JJ. The role of non-invasive imaging in the risk stratification of asymptomatic diabetic subjects. Eur Heart J 2006;27:905-912
- Folsom AR, Kronmal RA, Detrano RC, et al. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence. The Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med 2008;168:1333-9
- Taylor AJ, Burk AP, O'Malley PG, et al. A comparison of the Framingham risk index, coronary artery calcification, and culprit plaque morphology in sudden cardiac death. Circulation 2000;101:1243-1248
- Rumberger JA. Tomographic plaque imaging with CT: technical considerations and capabilities. Prog Cardiovasc Dis 2003;46:123-134
- Achenbach S, Hoffmann U, Ferencik M, et al. Tomographic coronary angiography by EBCT and MDCT. Prog Cardiovasc Dis 2003;46:185-95
- Bielak LF, Rumberger JA, Sheedy PF, et al. Probabilistic model for prediction of angiographically defined obstructive coronary artery disease using electron beam computed tomography calcium score strata. Circulation 2000;102:380-5
- Vliegenthart R, Oudkerk M, Hofman A, et al. Coronary calcification improves cardiovascular risk prediction in the elderly. Circulation 2005;112:572-7
- Kondos GT, Hoff JA, Sevrukov A, et al. Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults. Circulation 2003;102:2571-6
- Pletcher MJ, Tice JA, Pignone M, Browner WS. Using the coronary artery calcium score to predict coronary heart disease events. A systematic review and meta-analysis. Arch Intern Med 2004;164:1285-92
- Arad Y, Spadaro LA, Goodman K, et al. Prediction of coronary events with electron beam computed tomography. J Am Coll Cardiol 2000;36:1253-60
- Grundy SG. Atherosclerosis imaging for risk assessment and primary prevention of cardiovascular disease. Prog Cardiovasc Dis 2003;46:115-121
- Shaw LJ, Raggi P, Schisterman E, et al. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology 2003;228:826-33
- Greenland P, Labree L, Azen SP, et al. Coronary artery calcium score combined for Framingham score for risk prediction in asymptomatic individuals. J Am Med Association 2004;29:210-5
- Lakoski SG, Greenland P, Wong ND, et al. Coronary artery calcium scores and risk for cardiovascular events in women classified as “low risk” based on Framingham risk score. The Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med 2007;167:2437-42
- Elkeles RS, Godsland IF, Feher MD, et al. Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study. Eur Heart J 2008;29:2244-51
- Ramakrishna G, Miller TD, Breen JF, et al. Relationship and prognostic value of coronary artery calcification by electron beam computed tomography to stress-induced ischemia by single photon emission computed tomography. Am Heart J 2007;153:807-14
- Budoff MJ, Gul KM. Expert review on coronary calcium.Vasc Health Risk Manag 2008;4:315-324
- Qu W, Le TT, Azen SP, et al. Value of coronary artery calcium scanning by computed tomography for predicting coronary heart disease in diabetic subjects. Diabetes Care 2003;26:905-10
- Iwasaki K, Matsumoto T, Aono H, et al. Prevalence of subclinical atherosclerosis in asymptomatic diabetic patients by 64 slice computed tomography. Coron Artery Dis 2008;19:195-201
- Anand DV, Lim E, Hopkins D, et al. Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. Eur Heart J 2008;29:2373-81
- Sheth T, Amlani S, Ellins ML, et al. Computed tomographic coronary angiographic assessment of high-risk coronary anatomy in patients with suspected coronary artery disease and intermediate pretest probability. Am Heart J 2008;255:918-23
- Scholte AJHA, Schuijf JD, Kharagjitsingh AV, et al. Prevalence of coronary artery disease and plaque morphology assessed by multislice computed tomography, coronary angiography, and calcium scoring in asymptomatic patients with type 2 diabetes. Heart 2008;94:290-295
- Choi EK, Choi SI, Rivera JJ, et al. Coronary computed tomography angiography as a screening tool for the detection of occult coronary artery disease in asymptomatic individuals. J Am Coll Cardiol 2008;52:357-65
- Henneman MM, Schuijf JD, Pundziute G, et al. Noninvasive evaluation with multislice computed tomography in suspected acute coronary syndrome. Plaque morphology on multislice computed tomography versus coronary calcium score. J Am Coll Cardiol 2008;52:216-22
- Scholte AJHA, Schuijf JD, Kharagjitsingh AV, et al. Different manifestations of coronary artery disease by stress SPECT myocardial perfusion imaging, coronary calcium scoring, and multislice CT coronary angiography in asymptomatic patients with type 2 diabetes mellitus. J Nucl Cardio 2008;15:503-9
- Pundziute G, Schuijf JD, Jukema JW, et al. Evaluation of plaque characteristics in acute coronary syndromes: non-invasive assessment with multi-slice computed tomography and invasive evaluation with intravascular ultrasound radiofrequency data analysis. Eur Heart J 2008; doi:10.1093/eurheartj/ehn356
- Cordeiro MAS, Lima JAC. Atherosclerotic plaque characterization by multidetector row computed tomography angiography. J Am Coll Cardiol 2006;47:C40-7
- Earls JP, Berman EL, Urban BA, et al. Prospectively gated transverse coronary CT angiography versus retrospectively gated helical technique: improved image quality and reduced radiation dose. Radiology 2008;246:742-53
- Berman DS, Hachamovitch R, Shaw LJ, et al. Roles of nuclear cardiology, cardiac computed tomography, and cardiac magnetic resonance: noninvasive risk stratification and a conceptual framework for the selection of noninvasive imaging tests in patients with known or suspected coronary artery disease. J Nucl Med 2006;47:1107-18
- Wilensky RL, Song HK, Ferrari VA. Role of magnetic resonance and intravascular magnetic resonance in the detection of vulnerable plaques. J Am Coll Cardiol 2006;47:C48-56
- Jahnke C, Nagel E, Gebker R, et al. Prognostic value of cardiac magnetic resonance stress tests: adenosine-stress perfusion and dobutamine stress wall motion imaging. Circulation 2007;115:1769-76
- Nagel E, Lehmkuhl HB, Bocksch W, et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI. Comparison with dobutamine stress echocardiography. Circulation 1999;99:763-70
- Schwitter J, Wacker CM, van Rossum AC, et al. MR-IMPACT: a comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J 2008;29:480-9
- Williams RR, et al. Usefulness of cardiovascular family history data for population-based preventive medicine and medical research (the Health Family Tree Study and the NHLBI Family Heart Study). Am J Cardiol 2001;87:129-35
- Nasir K, Budoff MJ, Wong ND, et al. Family history of premature coronary heart disease and coronary artery calcification: Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2007;116:619-26
- Alonso R, Mata N, Castillo S, et al. Cardiovascular disease in familial hypercholesterolemia: influence of low density lipoprotein receptor mutation type and classic risk factors. Atherosclerosis 2008;200:315-21
- Arnett DK, Baird AE, Barkley RA, et al. Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease: A Scientific Statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 2007;115:2878-901
- Samani NJ, Erdmann J, Hall AS, et al. N Engl J Med 2007;357:443-453
- Broeckel U, Hengstenberg C, Mayer B, et al. Nat Genet 2002;30:210-214
- Olivieri F, Antonicelli R, Cardelli M, et al. Mechanisms of Ageing and Development. 2006;127:552-559
- Mccaskie P. A., Beilby JP, Hung J, et al. 15-Lipoxygenase gene variants are associated with carotid plaque but not carotid intima-media thickness. Hum Genet 2008;123:445-53
- Tom B, Garrelds IM, Scalbert E, et al. ACE- versus chymase-dependent angiotensin II generation in human coronary arteries: a matter of efficiency? Arteriosclerosis, Thrombosis, and Vascular Biology 2003;23:251-6
- Ferrario CM, Strawn WB. Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. American Journal of Cardiology 2006;98:121-8
- Niemiec P, Zak I, Wita K. The D-allele of angiotensin-I converting enzyme gene insertion/deletion polymorphism is associated with the severity of atherosclerosis. Clin Chem Lab Med 2008;46:446-52
- Ouwehand WH. Platelet genomics and the risk of atherothrombosis. J Thromb Haemost 2007;5:188-95
- Ercan B, Tamer L, Sucu N, et al. Factor V Leiden and prothrombin G20210A gene polymorphisms in patients with coronary artery disease. Yonsei Med J 2008;49:237-43
- Sabatine MS, Ploughman L, Simonsen KL, et al. Association between ADAMTS-1 MMP Gene Variation, Coronary Heart Disease, and Benefit of Statin Therapy. Arteriosclerosis, Thrombosis, and Vascular Biology 2008;28:562-7
- The Wellcome Trust Case Control Consortium. Genome-wide association study of 14000 cases of seven common diseases and 3000 shared controls. Nature 2007;447:661-83
- Wang L, Hauser ER, Shah SH, et al. Polymorphisms of the tumor suppressor LSAMP are associated with left main coronary artery disease. Ann Hum Genet 2008;72:443-53
- Moldoveanu E, Tanaseanu C, Tanaseanu S, et al. Plasma markers of endothelial dysfunction in type 2 diabetics. European J Intern Med 2006;17(1):38-42
- Villanueva FS. Molecular imaging of cardiovascular disease using ultrasound. J Nucl Cardiol 2008;15: 576-86
- Langer HF, Haubner R, Pichler BJ, Gawaz M. Radionuclide imaging: a molecular key to the atherosclerotic plaque. J Am Coll Cardiol 2008;52:1-12
- Tegner J, Skogsberg J, Bjorkegren J. Multi-organ, whole-genome measurements and reverse engineering to uncover gene networks underlying complex traits. Journal of Lipid Research 2007;48:267-77
- Son J, Pang B, Mcfaline JL, et al. Surveying the damage: the challenges of developing nucleic acid biomarkers of inflammation. Mol Biosyst 2008;4:902-8
- Watson AD. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res 2006;47:2101-11
- You SA, Archacki SR, Angheloiu G, et al. Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosis. Physiol Genomics 2003;13:25-30
- Schadt EE, Lum PY. Reverse engineering gene networks to identify key drivers of complex disease phenotypes. Journal of Lipid Research 2006;47:2601-13
- Lusis AJ. A thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Editorial. J Lipid Res 2006;47:1887-90
- Zimmerli LU, Schiffer E, Zurbig P, et al. Urinary proteomic biomarkers in coronary artery disease. Mol Cell Proteomics 2008;7:290-8
- Lepedda AJ, Cigliano A, Cherchi GM, et al. A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. Atherosclerosis 2008; doi:10.1016/j.atherosclerosis.2008.07.001
- Blanco-Colio LM, Martin-ventura JL, Vivanco F, et al. Biology of atherosclerotic plaques: what we are learning from proteomic analysis. Cardiovasc Res 2006;72:18-29
- Sharma P, Kumar J, Garg G, et al. Detection of altered global DNA methylation in coronary artery disease patients. DNA and Cell Biology 2008;27:357-65